Patient Experiences and Safety Concerns with Weight-Loss Drugs Called GLP-1 Receptor Agonists in Jeddah, Saudi Arabia
Updated
Abstract
Patients' perceptions of glucagon-like peptide-1 (GLP-1) receptor agonists remain largely unexplored.
- Obesity is recognized as a significant public health issue.
- GLP-1 receptor agonists are newer medications for obesity management.
- There is limited understanding of patients' views on the benefits and safety of these medications.
- Concerns exist regarding the cost and accessibility of GLP-1 receptor agonists.
Simplified